These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 7929420)
1. Structure-function studies of human arylamine N-acetyltransferases NAT1 and NAT2. Functional analysis of recombinant NAT1/NAT2 chimeras expressed in Escherichia coli. Dupret JM; Goodfellow GH; Janezic SA; Grant DM J Biol Chem; 1994 Oct; 269(43):26830-5. PubMed ID: 7929420 [TBL] [Abstract][Full Text] [Related]
2. Site-directed mutagenesis of recombinant human arylamine N-acetyltransferase expressed in Escherichia coli. Evidence for direct involvement of Cys68 in the catalytic mechanism of polymorphic human NAT2. Dupret JM; Grant DM J Biol Chem; 1992 Apr; 267(11):7381-5. PubMed ID: 1559981 [TBL] [Abstract][Full Text] [Related]
3. Monomorphic and polymorphic human arylamine N-acetyltransferases: a comparison of liver isozymes and expressed products of two cloned genes. Grant DM; Blum M; Beer M; Meyer UA Mol Pharmacol; 1991 Feb; 39(2):184-91. PubMed ID: 1996083 [TBL] [Abstract][Full Text] [Related]
4. Identification of amino acids imparting acceptor substrate selectivity to human arylamine acetyltransferases NAT1 and NAT2. Goodfellow GH; Dupret JM; Grant DM Biochem J; 2000 May; 348 Pt 1(Pt 1):159-66. PubMed ID: 10794727 [TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of functional rat arylamine N-acetyltransferase 3: comparisons with rat arylamine N-acetyltransferases 1 and 2. Walraven JM; Doll MA; Hein DW J Pharmacol Exp Ther; 2006 Oct; 319(1):369-75. PubMed ID: 16829624 [TBL] [Abstract][Full Text] [Related]
6. Cloning, sequencing, and recombinant expression of NAT1, NAT2, and NAT3 derived from the C3H/HeJ (rapid) and A/HeJ (slow) acetylator inbred mouse: functional characterization of the activation and deactivation of aromatic amine carcinogens. Fretland AJ; Doll MA; Gray K; Feng Y; Hein DW Toxicol Appl Pharmacol; 1997 Feb; 142(2):360-6. PubMed ID: 9070359 [TBL] [Abstract][Full Text] [Related]
7. Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases. Hein DW; Doll MA; Rustan TD; Gray K; Feng Y; Ferguson RJ; Grant DM Carcinogenesis; 1993 Aug; 14(8):1633-8. PubMed ID: 8353847 [TBL] [Abstract][Full Text] [Related]
9. Genetic variants of N-acetyltransferases 1 and 2 (NAT1 and NAT2) in cynomolgus and rhesus macaques. Uno Y; Murayama N; Yamazaki H Biochem Pharmacol; 2020 Jul; 177():113996. PubMed ID: 32339492 [TBL] [Abstract][Full Text] [Related]
10. Effect of arylamine acetyltransferase Nat3 gene knockout on N-acetylation in the mouse. Sugamori KS; Brenneman D; Wong S; Gaedigk A; Yu V; Abramovici H; Rozmahel R; Grant DM Drug Metab Dispos; 2007 Jul; 35(7):1064-70. PubMed ID: 17403913 [TBL] [Abstract][Full Text] [Related]
11. Molecular and Functional Characterization of N-Acetyltransferases NAT1 and NAT2 in Cynomolgus Macaque. Uno Y; Murayama N; Yamazaki H Chem Res Toxicol; 2018 Nov; 31(11):1269-1276. PubMed ID: 30358977 [TBL] [Abstract][Full Text] [Related]
12. Isoform-selective inactivation of human arylamine N-acetyltransferases by reactive metabolites of carcinogenic arylamines. Liu L; Wagner CR; Hanna PE Chem Res Toxicol; 2009 Dec; 22(12):1962-74. PubMed ID: 19842618 [TBL] [Abstract][Full Text] [Related]
13. Arylamine N-acetyltransferases. Expression in Escherichia coli, purification, and substrate specificities of recombinant hamster monomorphic and polymorphic isozymes. Wagner CR; Bergstrom CP; Koning KR; Hanna PE Drug Metab Dispos; 1996 Feb; 24(2):245-53. PubMed ID: 8742238 [TBL] [Abstract][Full Text] [Related]
14. Metabolic activation of aromatic and heterocyclic N-hydroxyarylamines by wild-type and mutant recombinant human NAT1 and NAT2 acetyltransferases. Hein DW; Rustan TD; Ferguson RJ; Doll MA; Gray K Arch Toxicol; 1994; 68(2):129-33. PubMed ID: 8179482 [TBL] [Abstract][Full Text] [Related]
15. Arylamine N-acetyltransferases: characterization of the substrate specificities and molecular interactions of environmental arylamines with human NAT1 and NAT2. Liu L; Von Vett A; Zhang N; Walters KJ; Wagner CR; Hanna PE Chem Res Toxicol; 2007 Sep; 20(9):1300-8. PubMed ID: 17672512 [TBL] [Abstract][Full Text] [Related]
16. Generation and functional characterization of arylamine N-acetyltransferase Nat1/Nat2 double-knockout mice. Sugamori KS; Wong S; Gaedigk A; Yu V; Abramovici H; Rozmahel R; Grant DM Mol Pharmacol; 2003 Jul; 64(1):170-9. PubMed ID: 12815173 [TBL] [Abstract][Full Text] [Related]
17. Liver-selective expression of human arylamine N-acetyltransferase NAT2 in transgenic mice. Sugamori KS; Brenneman D; Grant DM Drug Metab Dispos; 2011 May; 39(5):882-90. PubMed ID: 21317369 [TBL] [Abstract][Full Text] [Related]
19. Metabolic activation of N-hydroxy-2-aminofluorene and N-hydroxy-2-acetylaminofluorene by monomorphic N-acetyltransferase (NAT1) and polymorphic N-acetyltransferase (NAT2) in colon cytosols of Syrian hamsters congenic at the NAT2 locus. Hein DW; Doll MA; Gray K; Rustan TD; Ferguson RJ Cancer Res; 1993 Feb; 53(3):509-14. PubMed ID: 8425184 [TBL] [Abstract][Full Text] [Related]
20. Recombinant rat and hamster N-acetyltransferases-1 and -2: relative rates of N-acetylation of arylamines and N,O-acyltransfer with arylhydroxamic acids. Jones RF; Land SJ; King CM Carcinogenesis; 1996 Aug; 17(8):1729-33. PubMed ID: 8761433 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]